Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia

  • Vargas-Poussou, Rosa|||0000-0002-4169-0680
  • Claverie-Martin, F.
  • Prot-Bertoye, C.
  • Carotti, V.
  • Van Der Wijst, J.
  • Perdomo-Ramirez, A.
  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • Hureaux, M.
  • Bos, C.|||0000-0001-5016-9435
  • Latta, F.
  • Houillier, Pascal
  • Hoenderop, J.G.J.|||0000-0002-1816-8544
  • De Baaij, J.H.F.|||0000-0003-2372-8486
Hypomagnesaemia with secondary hypocalcaemia (HSH) is a rare autosomal recessive disorder caused by pathogenic variants in TRPM6, encoding the channel-kinase transient receptor potential melastatin type 6. Patients have very low serum magnesium (Mg2+) levels and suffer from muscle cramps and seizures. Despite genetic testing, a subgroup of HSH patients remains without a diagnosis. In this study, two families with an HSH phenotype but negative for TRPM6 pathogenic variants were subjected to whole exome sequencing. Using a complementary combination of biochemical and functional analyses in overexpression systems and patient-derived fibroblasts, the effect of the TRPM7-identified variants on Mg2+ transport was examined. For the first time, variants in TRPM7 were identified in two families as a potential cause for hereditary HSH. Patients suffer from seizures and muscle cramps due to magnesium deficiency and episodes of hypocalcaemia. In the first family, a splice site variant caused the incorporation of intron 1 sequences into the TRPM7 messenger RNA and generated a premature stop codon. As a consequence, patient-derived fibroblasts exhibit decreased cell growth. In the second family, a heterozygous missense variant in the pore domain resulted in decreased TRPM7 channel activity. We establish TRPM7 as a prime candidate gene for autosomal dominant hypomagnesaemia and secondary hypocalcaemia. Screening of unresolved patients with hypocalcaemia and secondary hypocalcaemia may further establish TRPM7 pathogenic variants as a novel Mendelian disorder.
Dipòsit Digital de Documents de la UAB
Publication

Changes in glucagon-like peptide 1 and 2 levels in people with obesity after a diet-induced weight-loss intervention are related to a specific microbiota signature, A prospective cohort study

  • Rodríguez-Peña, M-Mar
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Seco, Jesus|||0000-0002-4049-8873
  • Ceperuelo Mallafré, Victòria|||0000-0002-4460-9761
  • Caballé Mestres, Adrià|||0000-0002-2388-4713
  • Pérez-Brocal Vicente|||0000-0002-1927-9676
  • Attolini, Camille Stephan-Otto
  • Moya, Andrés|||0000-0002-2867-1119
  • Llauradó, Gemma|||0000-0002-3237-6366
  • Megía, Ana|||0000-0002-5101-9452
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis

  • García-Castaño, Alejandro|||0000-0002-9734-6600
  • Perdomo-Ramirez, Ana|||0000-0002-2562-2119
  • Vall-Palomar, Mònica|||0000-0002-4133-5814
  • Ramos-Trujillo, Elena|||0000-0002-7080-7649
  • Madariaga, Leire|||0000-0002-4032-9842
  • Ariceta Iraola, Gema|||0000-0003-1763-1098
  • Claverie-Martin, Felix|||0000-0003-2468-3267
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive tubulopathy characterized by excessive urinary wasting of magnesium and calcium, bilateral nephrocalcinosis, and progressive chronic renal failure in childhood or adolescence. FHHNC is caused by mutations in CLDN16 and CLDN19, which encode the tight-junction proteins claudin-16 and claudin-19, respectively. Most of these mutations are missense mutations and large deletions are rare. We examined the clinical and biochemical features of a Spanish boy with early onset of FHHNC symptoms. Exons and flanking intronic segments of CLDN16 and CLDN19 were analyzed by direct sequencing. We developed a new assay based on Quantitative Multiplex PCR of Short Fluorescent Fragments (QMPSF) to investigate large CLDN16 deletions. Genetic analysis revealed two novel compound heterozygous mutations of CLDN16, comprising a missense mutation, c.277G>A; p.(Ala93Thr), in one allele, and a gross deletion that lacked exons 4 and 5,c.(840+25_?)del, in the other allele. The patient inherited these variants from his mother and father, respectively. Using direct sequencing and our QMPSF assay, we identified the genetic cause of FHHNC in our patient. This QMPSF assay should facilitate the genetic diagnosis of FHHNC. Our study provided additional data on the genotypic spectrum of the CLDN16 gene. We report the clinical and genetic findings of a child diagnosed with FHHNC, a rare autosomal recessive disease characterized by excessive renal magnesium and calcium wasting, bilateral nephrocalcinosis, and progressive chronic renal failure. Two novel compound heterozygous mutations of CLDN16, c.277G>A, p.(A93T) and a gross deletion involving exons 4 and 5, inherited from the patient's parents, were identified. We developed a new assay based on Quantitative Multiplex PCR of Short Fluorescent Fragments, which should facilitate the genetic diagnosis of FHHNC.